Pompe disease diagnosis and management guideline
- PMID: 16702877
- PMCID: PMC3110959
- DOI: 10.1097/01.gim.0000218152.87434.f3
Pompe disease diagnosis and management guideline
Erratum in
- Genet Med. 2006 Jun;8(6):382. ACMG Work Group on Management of Pompe Disease [removed]; Case, Laura [corrected to Case, Laura E]
Figures
Similar articles
-
Infantile-onset Pompe disease: Diagnosis and management.Arch Argent Pediatr. 2019 Aug 1;117(4):271-278. doi: 10.5546/aap.2019.eng.271. Arch Argent Pediatr. 2019. PMID: 31339275 English, Spanish.
-
Genetic counseling in Pompe disease.Acta Myol. 2011 Dec;30(3):179-81. Acta Myol. 2011. PMID: 22616199 Free PMC article.
-
Gastrointestinal symptoms in late-onset Pompe disease: Early response to enzyme replacement therapy.J Neurol Sci. 2015;353(1-2):181-2. doi: 10.1016/j.jns.2015.04.012. Epub 2015 Apr 17. J Neurol Sci. 2015. PMID: 25911022 No abstract available.
-
Clinical guidelines for late-onset Pompe disease.Rev Neurol. 2012 Apr 16;54(8):497-507. Rev Neurol. 2012. PMID: 22492103 Review. English, Spanish.
-
The Brazilian consensus on the management of Pompe disease.J Pediatr. 2009 Oct;155(4 Suppl):S47-56. doi: 10.1016/j.jpeds.2009.07.006. J Pediatr. 2009. PMID: 19765410 Review. No abstract available.
Cited by
-
The value of knowing: preferences for genetic testing to diagnose rare muscle diseases.Orphanet J Rare Dis. 2024 Apr 22;19(1):173. doi: 10.1186/s13023-024-03160-7. Orphanet J Rare Dis. 2024. PMID: 38649872 Free PMC article.
-
104-week efficacy and safety of cipaglucosidase alfa plus miglustat in adults with late-onset Pompe disease: a phase III open-label extension study (ATB200-07).J Neurol. 2024 May;271(5):2810-2823. doi: 10.1007/s00415-024-12236-0. Epub 2024 Feb 28. J Neurol. 2024. PMID: 38418563 Free PMC article. Clinical Trial.
-
Diagnostic delay in late-onset Pompe disease among Chinese patients: A retrospective study.JIMD Rep. 2023 Dec 20;65(1):39-46. doi: 10.1002/jmd2.12404. eCollection 2024 Jan. JIMD Rep. 2023. PMID: 38186848 Free PMC article.
-
Severe CNS involvement in a subset of long-term treated children with infantile-onset Pompe disease.Mol Genet Metab. 2024 Feb;141(2):108119. doi: 10.1016/j.ymgme.2023.108119. Epub 2023 Dec 22. Mol Genet Metab. 2024. PMID: 38184429
-
Pompe disease in China: clinical and molecular characteristics.Front Cardiovasc Med. 2023 Dec 14;10:1261172. doi: 10.3389/fcvm.2023.1261172. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 38162137 Free PMC article.
References
-
- Hirschhorn R, Reuser AJJ. Glycogen storage disease type II: acid alpha-glucosidase (acid maltase) deficiency. In: Beaudet A, Scriver C, Sly W, et al., editors. The Metabolic and Molecular Bases of Inherited Disease. New York: McGraw Hill; 2001. pp. 3389–3420.
-
- Kishnani PS, Howell RR. Pompe disease in infants and children. J Pediatr. 2004;144:S35–S43. - PubMed
-
- Pompe JC. Over idiopatische hypertrophie van het hart. Ned Tijdshr Geneeskd. 1932;76:304.
-
- van den Hout HM, Hop W, van Diggelen OP, Smeitink JA, et al. The natural course of infantile Pompe’s disease: 20 original cases compared with 133 cases from the literature. Pediatrics. 2003;112:332–340. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical